SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001213900-22-079487
Filing Date
2022-12-13
Accepted
2022-12-13 15:47:48
Documents
17
Period of Report
2022-12-13
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea170120-8k_inmedpharma.htm   iXBRL 8-K 30528
2 LETTER AGREEMENT DATED DECEMBER 12, 2022 WITH BRIO FINANCIAL GROUP ea170120ex10-1_inmedpharma.htm EX-10.1 40286
3 CONSULTING AGREEMENT DATED DECEMBER 12, 2022 WITH JONATHAN TEGGE ea170120ex10-2_inmedpharma.htm EX-10.2 137633
4 PRESS RELEASE DATED DECEMBER 12, 2022 ea170120ex99-1_inmedpharma.htm EX-99.1 18693
8 GRAPHIC ex10-1_001.jpg GRAPHIC 4820
9 GRAPHIC ex99-1_001.jpg GRAPHIC 5102
  Complete submission text file 0001213900-22-079487.txt   457399

Data Files

Seq Description Document Type Size
5 XBRL SCHEMA FILE inm-20221213.xsd EX-101.SCH 3233
6 XBRL LABEL FILE inm-20221213_lab.xml EX-101.LAB 34240
7 XBRL PRESENTATION FILE inm-20221213_pre.xml EX-101.PRE 22364
11 EXTRACTED XBRL INSTANCE DOCUMENT ea170120-8k_inmedpharma_htm.xml XML 3741
Mailing Address SUITE 310, 815 W. HASTINGS STREET VANCOUVER A1 V6C 1B4
Business Address SUITE 310, 815 W. HASTINGS STREET VANCOUVER A1 V6C 1B4 (604) 669-7207
InMed Pharmaceuticals Inc. (Filer) CIK: 0001728328 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 0630
Type: 8-K | Act: 34 | File No.: 001-39685 | Film No.: 221459599
SIC: 2834 Pharmaceutical Preparations